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Utilizing Rapid Multiple-Locus Variable-Number Tandem-Repeat
Analysis Typing To Aid Control of Hospital-Acquired Clostridium
difficile Infection: a Multicenter Study
Katherine Hardy,a,b Susan Manzoor,b Claire Marriott,c Helen Parsons,d Claire Waddington,e Savita Gossain,a Ala Szczepura,e
Nigel Stallard,d and Peter M. Hawkeya,b
West Midlands Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, United Kingdoma; School of Immunity and Infection, University of
Birmingham, Birmingham, United Kingdomb; Research and Development, Heart of England NHS Foundation Trust, Birmingham, United Kingdomc; Division of Health
Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdomd; and Warwick Medical School, University of Warwick, Coventry, United Kingdome
The early identification of outbreaks is crucial for the control of Clostridium difficile infection. This study aimed to determine if
the number of hospital-acquired C. difficile infections could be reduced by rapidly typing C. difficile strains using multiple-locus
variable-number tandem-repeat analysis (MLVA) compared to typing using PCR ribotyping. A total of 16 hospitals were re-
cruited to the study, and all periods of increased incidence (PIIs) of C. difficile infection were identified. The hospitals were ran-
domized into two study arms, the test and the control, with all isolates typed in the test usingMLVA and in the control using
PCR ribotyping. Following a PII, each hospital received a structured questionnaire regarding control measures implemented or
stopped prior to or following the typing results. During the study period, there were a total of 1,682 hospital-apportioned C. dif-
ficile toxin-positive cases, with 868 in the control and 814 in the test, with modeling demonstrating no differences between the
two arms. A total of 245 PIIs occurred, involving 785 patients. There was a significant difference in the mean turnaround time
between the ribotyping andMLVA typing (13.6 and 5.3 days, respectively [P< 0.001]). The discriminatory ability of MLVAwas
greater than ribotyping, with 85 outbreaks being confirmed by ribotyping and 62 byMLVA. In the test arm, 40.6% of respon-
dents strongly agreed that the typing result had aided their management of clusters, as opposed to 9.9% in the control. The study
demonstrated the utility of rapidly typing C. difficile strains, demonstrating that it aided the management of clusters, enabling
effective targeting of infection control resources.
Clostridium difficile is an important cause of hospital-acquiredinfection, causing a range of symptoms from diarrhea to toxic
megacolon and death. In the mid-2000s, rates of C. difficile infec-
tion (CDI) rose across North America and Europe (8, 12). Due to
the introduction of a number of control measures, including an-
tibiotic stewardship, increased cleaning, and epidemiological typ-
ing of isolates, the rates have fallen (4, 5). Rapidly identifying
definite transmission episodes is important for the effective con-
trol of outbreaks. Conversely, demonstrating that clusters of CDI
do not constitute an outbreak can also assist management by en-
abling the cessation of specific infection control measures. In or-
der to manage clusters of C. difficile infection in a timely manner,
a typing technique with good discriminatory power and a rapid
turnaround time is required. A variety of techniques are avail-
able, including pulsed-field gel electrophoresis (PFGE), multi-
locus sequencing typing (MLST), PCR ribotyping, and multi-
ple-locus variable-number tandem-repeat analysis (MLVA)
(11). All of the techniques have limitations, with PFGE being
time consuming, MLST lacking the discriminatory power, and
PCR ribotyping requiring the interpretation of analogue data.
In the United Kingdom, a free-of-charge service has been pro-
vided by the regional public health laboratories of the Health
Protection Agency (HPA) since 2007 for PCR ribotyping of all
isolates from periods of increased incidence (PIIs), which is
defined as two or more C. difficile toxin-positive cases in a ward
within a 28-day period (9). The turnaround time for the ri-
botyping service is 14 days, which makes rapid infection con-
trol intervention difficult. MLVA typing provides a greater dis-
criminatory ability and a reduced time in obtaining results
compared to PCR ribotyping and has been shown to have util-
ity in investigating clusters of isolates (13, 18).
The primary aim of this study was to determine if the number
of C. difficile cases acquired in the hospital could be reduced by
rapidly typing isolates using a highly discriminatory scheme com-
pared to typing isolates using PCR ribotyping and by introducing
targeted control measures. The secondary aim of this study was to
establish if a rapid service could be delivered to 16 hospitals with a
target turnaround time of 6 days. In addition, we obtained physi-
cian feedback on the impact typing had on the management of
clusters.
MATERIALS AND METHODS
Study setting and design. Since the introduction of national guidance in
2009 (5), all hospitals in England have routinely identified periods of
increased incidence (PIIs) of CDI, defined as two or more patients devel-
oping laboratory confirmedC. difficile infection within a 28-day period in
the sameward. A PII is considered closed if nomore cases occur within 28
days following the last case. Hospitals within the East andWest Midlands
submitted fecal samples from these cases to the Public Health Laboratory,
Birmingham, United Kingdom, for PCR ribotyping and MLVA typing.
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All typingwas requested and reported using the secureClostridiumdifficile
ribotyping network (CDRN) website.
During the period of May 2010 to June 2011, 16 hospitals (9 large
hospitals and 7 small/medium hospitals) from the East and West Mid-
lands were randomized into the control or test arm with randomization
stratified by hospital size. Hospitals continued to identify PIIs and submit
fecal samples for typing, with no changes to the service offered to hospitals
within the control arm. Samples from hospitals within the test arm were
typed using a modified MLVA protocol, and results were reported in real
time using secure e-mail addresses.
Each hospital followed their own protocol for the identification of C.
difficile toxin-positive patients and their own infection control procedures
for CDI, which were captured using questionnaires at the start of the
study.
Following cessation of the study, the isolates from the control arm
were also typed using MLVA and the isolates from the test arm were
ribotyped to compare the results of the two typing methods.
Laboratory procedures and reporting. All samples were cultured us-
ing the alcohol shock procedure with an equal amount of feces and etha-
nol being vortexed and then left at room temperature for 30 min. Two
drops of the suspension was placed on a C. difficile selective agar plate
(Oxoid, United Kingdom) and incubated anaerobically at 37°C for 48 h.
An individual colony displaying typical morphology of C. difficile was
picked for DNA extraction using the Chelex method and subcultured to
blood agar to check for purity (15). Ribotyping was carried out as de-
scribed previously on all isolates (15). For MLVA, 12 variable-number
tandem-repeat (VNTR) loci (A6Cd, B7Cd, C6Cd, E7Cd, G8Cd, CDR5,
CDR60, CD9, CD12, CD14, CD19, and CD44) were amplified by PCR as
described previously byManzoor et al., with the product size being deter-
mined using a 3130xlDNA sequencer (Applied Biosystems) (13). Analysis
was undertaken using BioNumerics software v4.61, and the summed tan-
dem-repeat differences (STRD) from all loci were calculated using the
Manhattan coefficient. A PII was confirmed as an outbreak by ribotyping
if two or more isolates had the same ribotype and by MLVA if the differ-
ence between the STRD of two or more isolates was4 (5). The report of
the MLVA data included an interpretative statement of the results.
Data collection. Prior to the commencement of the study, a question-
naire was sent to all participating hospitals to establish the method of C.
difficile testing, the isolation policywithin the hospital, details of antibiotic
policies, cleaning regimes, and basic demographics. Following the report-
ing of results from a PII, a short data collection form was sent to each
hospital to establish if, following the notification of the results, either
additional infection control measures had been introduced or measures
that had been introduced previously had been stopped. In addition, users
were asked to evaluate whether they considered that the typing result had
aided their management of clusters.
For each hospital, the number of hospital-apportioned C. difficile re-
ports, defined as patients who are in-patients and have had a specimen
taken at an acute hospital two or more days after the date of admission as
reported to the mandatory Department of Health surveillance scheme,
was obtained (www.hpa.org.uk).
Outcome measures and statistical analysis. The primary outcome
was the number of hospital-apportioned cases of C. difficile at each hos-
pital as reported to themandatory reporting scheme. A negative binomial
regression model was constructed to compare the number of hospital-
apportioned cases in the test and control arms of the study. The model
included the logarithm of the number of beds in the hospital as an offset
variable to compensate for the different hospital sizes. All statistical anal-
yses were conducted using R (version 2.12.1).
RESULTS
During the study period, there were a total of 1,682 hospital-ap-
portioned C. difficile toxin-positive cases from the 16 hospitals,
with 868 in the control and 814 in the test arm. The number of
cases per hospital ranged from 32 to 246 (Table 1). Modeling of
the differences in the number of hospital-apportioned C. difficile
toxin-positive cases between the control and the test arm using
negative binomial regression with the logarithm of the number of
beds in the hospital as an offset variable indicated that there were
no statistically significant differences between the two arms.
A total of 245 PIIs occurred, 119 in the control and 126 in the
test arm, with an overall mean of 15 per hospital and a range of 0
to 58 per hospital (Table 1). The PIIs involved 785 (46.7%) pa-
tients of the 1,682 hospital-apportioned cases identified through
mandatory reporting. The number of patients involved in a PII
ranged from 2 to 15. The mean length of a PII in the control arm
was 19.1 days and in the test arm was 19.9 days, with the longest
PII observed being 117 days.
TABLE 1 Data from each hospital, detailing the number of hospital-apportioned C. difficile cases, the number of PIIs, and the number of PIIs
confirmed as outbreaks by the two typing methodsa
Hospital
Study
arm
No. of mandatory
reported hospital-
apportioned C.
difficile cases
Rate of C. difficile
cases per 10,000
patient days
No. of
PIIs
Mean (min, max)
no. of cases per
PII
No. of PIIs confirmed
as outbreaks by
ribotyping
No. of PIIs confirmed
as outbreaks by
MLVA
A Control 32 1.7 3 3.0 (2, 4) 1 1
B Control 108 2.8 10 4.4 (2, 9) 7 7
C Control 48 2.1 5 2.6 (2, 3) 1 1
D Control 52 2.1 8 2.0 (2, 4) 2 1
E Control 246 3.5 58 3.2 (2, 10) 11 5
F Control 131 3.0 8 2.5 (2, 4) 2 2
G Control 156 3.1 8 5.8 (2, 10) 5 4
H Control 95 2.4 19 2.6 (2, 6) 3 1
I Test 63 2.7 3 3.3 (2, 4) 1 1
J Test 199 3.1 33 2.7 (2, 10) 9 7
K Test 46 4.3 3 3.3 (2, 5) 1 1
L Test 57 1.5 11 2.5 (2, 6) 2 2
M Test 74 1.8 15 2.9 (2, 8) 5 5
N Test 108 2.1 15 3.3 (2, 7) 5 4
O Test 167 3.5 46 3.7 (2, 15) 20 17
P Test 100 2.6 0 0 (NA, NA) 0 0
a Six PIIs contained two different outbreaks. NA, not available; min, minimum; max, maximum.
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Of the 785 patients involved in PIIs, typing results were avail-
able for 669 (85.2%) samples, C. difficile was not isolated in 114
samples, and there were insufficient samples in 2 cases. One hos-
pital in the test arm did not submit any samples for typing. The
time taken from the identification of the PII, taken as the date the
second sample in the PII was obtained, until receiving samples for
typing in the laboratorywas comparable in the two arms (14.0 and
14.4 days in the control and test arms, respectively). There was a
significant difference in the mean turnaround time from sample
receipt in the laboratory until reporting between the ribotyping
(control) andMLVA (test) typing (13.6 days and 5.3 days, respec-
tively [P 0.001]).
Of the 245 PIIs, outbreaks were confirmed in 69 (28.2%) in-
volving 218 cases by the typingmethod reported,MLVA in the test
and ribotyping in the control. A total of 34 outbreaks were con-
firmed in the control arm by ribotyping in 32/119 PIIs (26.9%),
with 2 outbreaks, caused by different ribotypes occurring in two of
the PIIs. In the test arm, 40 outbreakswere confirmed byMLVA in
37/126 PIIs (29.4%), with three of the PIIs containing 2 outbreaks.
Following the completion of the study, all isolates in the test
arm were typed using ribotyping and all isolates that were clus-
tered using ribotyping in the control arm were typed withMLVA.
This enabled exploration of any difference in the discriminatory
ability of the two techniques to be highlighted.Of the 34 outbreaks
confirmed by ribotyping in the control arm, MLVA typing con-
firmed 22, while ribotyping of the isolates in the test arm identified
51 outbreaks, as opposed to 40 with MLVA. There were no in-
stances in the test arm where MLVA identified an outbreak that
had not been identified by ribotyping. The ribotypes of the out-
breaks thatwere not confirmedbyMLVAdiffered. Combining the
test and control arms, a total of 156 cases were considered part of
an outbreak by MLVA, while with ribotype, 218 cases were con-
sidered part of an outbreak; thus, 62 cases were inappropriately
considered to be part of an outbreak by ribotyping. On examining
the number of outbreaks identified by MLVA, there were no sta-
tistical differences between the two intervention arms.
The appropriateness of defining an outbreak as isolates with an
STRD of4 was examined and demonstrated that, if an STRD of
1 had been used, only 45 of the 62 PIIs would have been classified
as outbreaks and that, if an STRD of 10 had been adopted, only an
additional 4 PIIs would have been classified as outbreaks. Three of
the four PIIs that were not considered to be outbreaks by MLVA
typing were the epidemic strains 106 and 027.
A total of 66 different ribotypes were identified in the control
and test arms of the study, with 24 ribotypes only present in single
samples. The most prevalent ribotype was 106 (81 samples), fol-
lowed by 027 (68 samples), 002 (51 samples), 014 (50 samples),
015 (45 samples), 078 (44 samples), 005 (42 samples), 001 (41
samples), and 020 (35 samples). All of the remaining ribotypes
had 16 samples. A total of 21 ribotypes were responsible for
outbreaks, with 9 ribotypes being common to both the test and
control arms and 11 ribotypes causing a single outbreak. The pre-
dominant ribotype causing outbreaks overall was 106 (19 out-
breaks) in six different hospitals, three in the control and three in
the test. However, the predominant ribotype causing outbreaks in
the test arm was 027, causing outbreaks in five different hospitals
(Fig. 1). Five outbreaks were due to ribotype 174 in the test arm,
but this occurred only at one hospital.
A total of 244 PII questionnaires, 120 from the control arm and
124 from the test, were completed. New measures were imple-
mented following the reporting of the typing results on a total of
55 occasions, 13 in the control and 42 in the test. The most fre-
quent interventions (55%) were the auditing of practices and the
teaching of staff. Following the reporting of typing results, 55mea-
sures in total were stopped, 41 in the control and 14 in the test. In
the control arm, the majority of measures were the auditing of
practices, while in the test, it was more varied. Physician feedback
on the value of the typing result in themanagement of the clusters
strongly favored MLVA rather than ribotyping. Thirteen (9.9%)
of the respondents from the control arm strongly agreed that typ-
ing had aided their management compared to 54 (40.6%) in the
test arm (Table 2).
DISCUSSION
Many studies have investigated the epidemiology of C. difficile
using a variety of typing methodologies, but the majority of
these have been retrospective, have not used the results to in-
fluence infection control practices in a timely manner, or have
assessed the impact of the results on transmission (1, 17, 20).
Although this study failed to demonstrate a difference in the
number of hospital-apportioned C. difficile cases between the
test and control arms, it did demonstrate that rapid results
could be delivered and that the rapid typing assisted the phy-
sicians in the management of C. difficile PIIs. There are a num-
ber of possible reasons for the failure to observe a difference
between the test and control arms. One of the most likely rea-
sons is the wide range and potential combinations of C. difficile
control measures. Following the large outbreaks and rise of C.
difficile in the United Kingdom in the early 2000s, the aware-
ness surrounding the control of C. difficile has been heightened
and a wide range of control measures have been instituted.
Guidance issued in the United Kingdom recommends the iden-
tification of PIIs, followed by the implementation of control
measures, including investigating with ribotyping, increased
cleaning, reviewing of antibiotics, auditing of infection control
practices, and educating the ward staff (5). The rate of identi-
fication of PIIs was much higher in some hospitals than in
others, which may be a true reflection of events, with some
hospitals having a greater number of sporadic cases, or may be
due to differences in protocols within hospitals for the identi-
fication of PIIs. This is highlighted by the hospital that, despite
repeated encouragement, was not able to submit any samples
for typing. If samples from PIIs were not sent for typing, this
FIG 1 Number of outbreaks caused by each ribotype in the control and test
arms of the study. Control, dark gray bars; test, light gray bars.
Hardy et al.
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could have resulted in potential outbreaks being missed and
potentially leading to an increase in cross transmission and a
rise in cases. Another limitation of PIIs is that they will only
identify clusters of ward-based transmission and not further
hospital-wide transmission.
Due to the need to act quickly following the identification of a
PII, most hospitals implement additional infection control mea-
sures prior to receiving the typing results, including increased
cleaning and changing cleaning products. This may, in part, ex-
plain why no difference is observed between the test and control
arms, with themeasures being applied rapidly in both arms.How-
ever, the availability of rapid typing results did result in a larger
number of new measures being introduced in the test arm com-
pared to the control arm, probably due to the results being avail-
able in a time to undertake relevant interventions while positive
patients were still in the ward. In the control arm, a greater num-
ber of measures were stopped after the results were received, with
the availability of typing results potentially resulting in cost sav-
ings.
Currently, there is a lot of debate regarding the optimal test
combinations for the diagnosis of C. difficile infection, with some
previously commonly used enzyme-linked immunosorbent assay
(ELISA) toxin detection tests being demonstrated to have poor
sensitivity and specificity (3, 6). Combination testing is now ad-
vocated, but multiple algorithms are being employed both within
laboratories in this study and throughout the United Kingdom
(19). The problemswith testing are highlighted in our study by the
fact that C. difficile could not be grown from 14.8% samples; this
could be due to the insensitivity of the culture technique or the
lack of specificity of the diagnostic testing. The culture positivity
rate is comparable to that observed by the CDRN in the United
Kingdom, where recovery in 2010 and 2011 was 89.9%.
This study demonstrated thatMLVA typing could be delivered
in a timely manner with the ability to aid the management of C.
difficile, with a difference of 8 days between the delivery of MLVA
typing and ribotyping results. Providing timely results enables ad-
ditional or more targeted control measures to be implemented in
the case of an outbreak or the cessation ofmeasures if the cluster is
demonstrated not to be an outbreak.
The discriminatory ability of a typing scheme is crucial in de-
fining whether an isolate is part of the outbreak or sporadic. Mul-
tiple MLVA schemes have been described for C. difficile, contain-
ing different numbers of loci and having various degrees of
discriminatory ability (13, 14, 18). The scheme adopted in this
study has been demonstrated to have good discriminatory ability
while also clustering isolates in concordance with PCR ribotyping
(13). A further complication in the analysis of C. difficileMLVA is
the definition of an outbreak. In MLVA schemes for other organ-
isms, for example, Mycobacterium tuberculosis, an isolate is only
considered part of the same outbreak if it has an identical MLVA
profile (10). However, for C. difficile, this has been demonstrated
to make the typing scheme too discriminatory with isolates that
are epidemiologically part of the same outbreak differing slightly
in the number of repeats and isolates from within the same feces
having different MLVA profiles (16). Different approaches to
overcome this have been proposed, with some studies using
summed tandem-repeat differences (STRD) to define relatedness,
with Marsh et al. stating that isolates with an STRD of 2 had a
high degree of genetic relatedness and Fawley et al. stating that an
STRD of 2 was indistinguishable and an STRD of 10 was
highly related (7, 14). Broukhanski and colleagues used Manhat-
tan distance-based clustering and then defined a cutoff of 90% to
define similarity (2). This technique involves a rooted tree and is
more suited to one of the studies rather than a routine service.
Preliminary work investigating clusters with the loci used in this
study demonstrated that an STRD of4 correlated with the epi-
demiology, and this is further reinforced by study results where
only four additional PIIs would have been called an outbreak if an
STRDof10 had been considered. Three of these PIIs were due to
epidemic ribotypes, and therefore, it is highly likely that they were
not linked and that they occurred by chance.
The difference in the discriminatory ability of the two tech-
niques is highlighted by the number of outbreaks detected. Out-
breaks defined by ribotyping could be further split byMLVA, thus
reducing the number of true outbreaks. MLVA provided greater
discrimination when applied to a wide range of ribotypes, high-
lighting its discriminatory ability in all strains and not just ri-
botype 027, as has been described previously. Interestingly, there
were no outbreaks confirmed by MLVA for ribotype 005. It may
be that transmission had not occurred between these patients or
that this is a highly evolving strain in which the MLVA loci are
relatively unstable and evolve rapidly.
A similar number of PIIs were observed in both the test and
control arms of the study, but when the ribotyping of isolates is
applied to both arms the test arm had a greater number of PIIs
confirmed as outbreaks. Thismay indicate thatmore transmission
was occurring in these hospitals in the test arm compared to the
control arm.
There is quite a marked difference in the ribotypes causing
outbreaks between the two arms, with the greatest number of
outbreaks being caused by ribotype 027 in the test arm, but only
two being due to ribotype 027 in the control. During the 2000s,
ribotype 027 was the most dominant strain circulating in the
United Kingdom, accounting for50% of all isolates typed in the
East and West Midlands in 2008 (www.hpa.org.uk). However,
the picture is changing with a greater number of types being ob-
served and this is reflected in this study.
Although this study does not demonstrate a reduction in C.
difficile hospital-apportioned cases between the test and control
arms, it does highlight and demonstrate the utility of rapid, dis-
criminatory typing. There was a clear difference in starting inter-
ventions in the MLVA arm, resulting in a more efficient use of
resources, which was supported by physician opinion. The avail-
ability of epidemiological typing at the local level is crucial in being
able to provide a timely and tailored service to users. It enables the
rapid sending and processing of samples and feedback of results,
allowing targeted measures to be taken, which in turn should lead
to reduced costs of interventions aimed at infection control.
TABLE 2 Responses to whether the typing result aided the management
of clusters
Study
arm
Strongly
agree Agree Disagree
Strongly
disagree
No
response
Control 13 97 13 4 4
Test 54 61 12 1 5
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